At POC, an informed prescription requires more than reading the indication and dosing section of a drug label,” says ...
The treatment goal should drive our choice of technology, rather than the technology driving the treatment,” says Allan Tsung ...
Alexander Geyer, MD, explores new findings linking longer reproductive lifespan to reduced bronchiectasis risk in women.
Yvette C. Terrie, BSPharm, discusses new recommendations for treating psoriasis and atopic dermatitis using biologic and oral ...
Urgent care has shown us what patients actually want and how to manage those expectations,” says Acey Albert, MD.
Biosimilars offer one of the clearest opportunities to lower costs and improve access,” says Maisha Draves, MD, MPH.
An Indigenous Food is Medicine (FIM) intervention involving medically and culturally tailored meals reduced the incidence of hospitalization and emergency department (ED) visits among patients with ...
What can I do to keep my daughter from losing her mother to cancer as I lost mine?” A friend asked that question after her ...
Safety evidence deserves particular scrutiny when adult data are applied to children,” says Christina Sheil, MD.
A meta-analysis that compared orforglipron doses supports titrating to the 36-mg maintenance dose for patients with obesity.
Nilay S. Shah, MD, MPH, discusses new data supporting selective use of CAC for those with borderline-to-intermediate risk.
Regulatory restrictions are deterring US physicians in solo and independent practices from charging less for cash payments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results